找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Glaucoma Surgery; Treatment and Techni Luigi Caretti,Lucio Buratto Book 2018 Springer International Publishing AG 2018 Micro-Invasive Glauc

[復(fù)制鏈接]
樓主: Limbic-System
31#
發(fā)表于 2025-3-26 21:05:30 | 只看該作者
Hypernovae and Gamma-Ray Bursts,Glaucoma Drainage Devices (GDDs) or shunts were proposed by Molteno and coll in 1968 for the treatment of refractory glaucomas, meaning those cases at a high risk of failure following filter surgery or in cases in which surgery was already not successful.
32#
發(fā)表于 2025-3-27 01:40:58 | 只看該作者
https://doi.org/10.1007/b117116In recent years, we have seen large development of laser technology in ophthalmology.
33#
發(fā)表于 2025-3-27 08:00:01 | 只看該作者
Interactive Data Selection in Power View,Following detailed and correct diagnosis, the best procedure for the treatment of glaucoma is chosen on the basis of:
34#
發(fā)表于 2025-3-27 10:30:22 | 只看該作者
Anatomy,In glaucoma surgery, comprehensive knowledge and understanding of the sclero-corneal limbus and the anatomy of the irido-corneal angle (Figs. 1.1, 1.2, 1.3, 1.4, 1.5, and 1.6) are absolutely essential.
35#
發(fā)表于 2025-3-27 17:41:05 | 只看該作者
Anesthesia,The anesthesia used in a surgical procedure for glaucoma depends primarily on the surgeon’s personal preferences. However, the complexity of the surgical procedure, the presence of other systemic clinical conditions and patient collaboration also play important roles.
36#
發(fā)表于 2025-3-27 19:22:15 | 只看該作者
37#
發(fā)表于 2025-3-27 21:58:02 | 只看該作者
Laser Antiglaucomatous Treatments,In recent years, we have seen large development of laser technology in ophthalmology.
38#
發(fā)表于 2025-3-28 02:13:01 | 只看該作者
The Choice of Glaucoma Treatment,Following detailed and correct diagnosis, the best procedure for the treatment of glaucoma is chosen on the basis of:
39#
發(fā)表于 2025-3-28 09:48:49 | 只看該作者
High energy neutrino and gamma-ray astronomy compliance to treatment. Several surgical options are available; they have different degrees of efficacy and also different complication rates. The decision regarding the treatment pathway is taken on a case by case basis, and this makes a standard treatment protocol difficult to define.
40#
發(fā)表于 2025-3-28 13:53:42 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 08:07
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
永安市| 靖安县| 泾阳县| 囊谦县| 连州市| 施甸县| 凌海市| 晋中市| 右玉县| 林西县| 滦平县| 五大连池市| 桃江县| 遂溪县| 广州市| 临澧县| 孝昌县| 北流市| 长泰县| 姜堰市| 抚顺市| 河间市| 忻城县| 肇源县| 石河子市| 吴堡县| 陆河县| 嘉义县| 双桥区| 福鼎市| 宝清县| 台南县| 额尔古纳市| 天镇县| 荣成市| 贵定县| 沙雅县| 福建省| 弥勒县| 清涧县| 临汾市|